探索新的分子机制背后的重复性流产在叶组织的重复性流产
Hui Ding1, Yajie Gao1, Yuan Gao1
1Department of Reproductive Medicine Center, Zhoukou Central Hospital, Zhoukou, China.
Scientific reports
|July 14, 2025
概括
复发性流产 (RPL) 通常是无法解释的. 这项研究确定了补充因子H相关蛋白1 (CFHR1) 作为一个关键的生物标志物,将其与RPL病例中的免疫失调和受损的决定性联系起来.
科学领域:
- 生殖生物学 生殖生物学
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 复发性流产 (RPL) 影响2.5%的女性,在50%以上的病例中具有特异性.
- 机械洞察力和可靠的生物标志物对于理解和管理RPL至关重要.
- 目前的诊断方法缺乏足够的灵敏度来检测异常性RPL.
研究的目的:
- 确定新的生物标志物并阐明异常性复发性妊娠损失的潜在机制.
- 整合多omics数据,以在RPL树叶组织中进行可靠的基因发现.
- 验证潜在的生物标志物并评估它们的诊断和病原遗传作用.
主要方法:
- 整合了三个人类的十足转录基因数据集 (GSE113790,GSE161969,GSE178535).
- 差异基因表达,权重基因共表达网络分析 (WGCNA) 和机器学习 (LASSO,SVM-RFE,RF) 用于特征基因识别.
- 使用RT-qPCR,免疫组织化学 (IHC),sssGSEA用于免疫透和体外结核化试验进行验证.
主要成果:
- 确定了10个关键基因,补充因子H相关蛋白1 (CFHR1) 成为最佳生物标志物.
- 过度表达CFHR1与补充/凝血通路失调和受损的决定性显著相关.
- RPL decidua显示巨细胞和γδ T 细胞增加;巨细胞水平与CFHR1正相关 (r=0.64,p<0.01).
- CFHR1显示了对RPL的高诊断疗效 (AUC=0.950).
结论:
- CFHR1是RPL病变的关键调解者,通过补充/凝血激活和免疫微环境重塑驱动疾病.
- CFHR1代表了一个有前途的多功能生物标志物用于RPL诊断.
- 准CFHR1可能为复发性流产提供新的治疗策略.
更多相关视频
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
3.5K
06:38Generation of a Mouse Artificial Decidualization Model with Ovariectomy for Endometrial Decidualization Research
Published on: July 27, 2022
5.6K
相关概念视频
Ovarian Cycle
1.9K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.9K
Nondisjunction
4.1K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.1K
